Friday, November 20, 2026 | 07:38 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

IPCA Lab board to mull stock split on 13 Nov

News image

Capital Market

The pharmaceutical company said its board will consider 2-for-1 stock split on 13 November 2021.

The board will consider splitting each share of face value Rs 2 each into two shares of face value of Re 1 each.

On 13 November 2021, the company's board will also consider Q2 results and interim dividend.

On a consolidated basis, net profit of IPCA Laboratories declined 31.26% to Rs 306.66 crore on 2.05% rise in net sales to Rs 1565.79 crore in Q1 June 2021 over Q1 June 2020.

IPCA is a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. It is one of the world's largest manufacturers and suppliers of over a dozen APIs.

 

Shares of IPCA Laboratories were down 1.03% at Rs 2,322. The stock hit a high of Rs 2,397.40 and a low of Rs 2,281.45 so far during the day.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 20 2021 | 12:10 PM IST